{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Talking Biotech with Dr. Kevin Folta","title":"Overcoming CAR-T Cell Bottlenecks - Dr. Andy Scharenberg","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/a2e93342\"></iframe>","width":"100%","height":180,"duration":2688,"description":"Immunotherapy is weaponizing the body's immune system against cancer or other disease. One of the most promising approaches is CAR-T cell therapy, yet as this technology has been implemented, it's limitations have been identified. Dr. Andy Scharenberg described the current drawbacks of CAR-T cells and how his company, Umoja, is re-engineering CAR-T cells in vivo to create more effective therapies, including approaches that can address solid tumors. Co-hosted by Donald Coon. www.umoja-biopharma.com","thumbnail_url":"https://img.transistorcdn.com/EFQPRMJfMphAaQcxzRzhsNHuwlpkADCznXm-32y-ENA/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzI4MTE2LzE2NDQw/ODk3ODktYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}